Marimed (MRMD) Total Current Liabilities (2011 - 2026)

Marimed (MRMD) has 16 years of Total Current Liabilities data on file, last reported at $63.8 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $63.8 million, up 15.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.8 million (up 15.28% YoY), and the FY2025 annual result was $59.1 million, up 18.12% from the prior year.
• Total Current Liabilities rose to $63.8 million in Q1 2026 per MRMD's latest filing, from $59.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $63.8 million in Q1 2026 and troughed at $24.5 million in Q1 2023.
• A 5-year average of $40.6 million and a median of $35.5 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 134.89% in 2022, then fell 28.3% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $26.5 million in 2022, then advanced by 16.5% to $30.9 million in 2023, then soared by 62.03% to $50.0 million in 2024, then rose by 18.12% to $59.1 million in 2025, then rose by 7.94% to $63.8 million in 2026.
• Business Quant data shows MRMD's Total Current Liabilities at $63.8 million in Q1 2026, $59.1 million in Q4 2025, and $56.6 million in Q3 2025.